Unibest

Pharmaceutical intermediates

Levofloxacin Intermediates

1 pharmaceutical intermediate for Levofloxacin. Indication: Respiratory tract infection; Cystic fibrosis; Bacterial infection.

提交项目All intermediates

About Levofloxacin

Originator
Johnson & Johnson
Indication
Respiratory tract infection; Cystic fibrosis; Bacterial infection
Approved Date
12/20/1996

Available intermediates

1 intermediate currently listed for Levofloxacin. Request specifications, documentation or a quotation for any item below.

Levofloxacin intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Levofloxacin carboxylic acid100986-89-8//

Other programs under L

(LCZ696)LanifibranorLapatinibLarotrectinibLasmiditanLazertinib MesylateLemborexantLenacapavir sodium

Building toward Levofloxacin?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →